Skip to main
LYEL
LYEL logo

Lyell Immunopharma (LYEL) Market Capitalization Overview

Market Cap: $139.57M as of Jul 1, 2025

$139.57M
Past Month+$10.62M (8.23%)
As of Jul 1, 2025, Lyell Immunopharma (LYEL) has a market capitalization of $139.57M. Over the past 30 days, its market cap has increased by 15%, while in the last 12 months, it has decreased by -26.05%.

Market capitalization represents the total value of Lyell Immunopharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Lyell Immunopharma (LYEL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Lyell Immunopharma (LYEL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Lyell Immunopharma (LYEL) Market Cap History

DateMarket CapChange
Jul 1, 2025$139.57M+15.00%
Jun 2, 2025$121.37M-12.55%
May 1, 2025$138.79M-2.95%
Apr 1, 2025$143.01M-26.68%
Mar 3, 2025$195.04M+13.16%
Feb 3, 2025$172.36M-9.38%
Jan 2, 2025$190.20M-25.87%

Lyell Immunopharma (LYEL) End of Year Market Cap History

DateMarket CapChange
2025$139.57M-26.05%
2024$188.73M-61.38%
2023$488.63M-43.50%
2022$864.87M-53.97%
2021$1.88B

FAQs About Lyell Immunopharma (LYEL) Market Cap

As of Jul 1, 2025, the market capitalization of Lyell Immunopharma (LYEL) is $139.57M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lyell Immunopharma’s market capitalization has increased by 8.23%, changing from $128.96M to $139.57M as of Jul 1, 2025.

In the last 3 months, Lyell Immunopharma’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Lyell Immunopharma’s market capitalization decreased from $488.63M in January to $188.73M in December, reflecting a -61.38% change.

In the past five years, Lyell Immunopharma (LYEL) has had a compound annual growth rate (CAGR) of -43.70% in market capitalization. This means its market cap has shrunk at an average rate of -43.70% per year.

Lyell Immunopharma (LYEL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.